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Background: Leptin, a hormone produced mainly by adipose tissue, regulates food intake 
and energy expenditure. It is involved in inflammatory diseases such as chronic obstructive 
pulmonary disease (COPD) and its deficiency is associated with increased susceptibility to the 
infection. The leptin receptor is expressed in the lung and in the neutrophils.
Methods: We measured the levels of leptin, tumor necrosis factor alpha (TNF-α) and soluble 
form of intercellular adhesion molecule-1 (sICAM-1) in sputum and plasma from 27 smoker and 
former smoker patients with stable COPD using ELISA methods. Further we analyzed leptin and 
its receptor expression in sputum cells from 16 COPD patients using immunocytochemistry.
Results: In plasma of COPD patients, leptin was inversely correlated with TNF-α and positively 
correlated with the patient weight, whereas the levels of sICAM-1 were positively correlated 
with TNF-α. In sputum of COPD patients leptin levels were correlated with forced expiratory 
volume in 1 second/forced vitality capacity. Additionally, increased levels of sputum leptin and 
TNF-α were observed in COPD former smokers rather than smokers. Further the expression of 
leptin receptor in sputum neutrophils was significantly higher in COPD former smokers than in 
smokers, and the expression of leptin and its receptor was positively correlated in neutrophils 
of COPD former smokers.
Conclusion: Our findings suggest a role of leptin in the local and systemic inflammation of 
COPD and, taking into account the involvement of neutrophils in this inflammatory disease, 
describe a novel aspect of the leptin/leptin receptor pathway in the regulation of host defense 
after smoking cessation.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow 
limitation and is associated with an abnormal inflammatory response to inhaled noxious 
particles, including cigarette smoke. Current or previous exposure to cigarette smoke 
is usually reported by COPD patients, and smoking cessation is the single most effec-
tive intervention to reduce the risk of developing COPD and stopping its progression.1 
Clinical and functional heterogeneity is a hallmark of COPD, and the forced expira-
tory volume in 1 second (FEV1) value and the FEV1/forced vitality capacity (FVC) 
ratio are considered the most important altered parameters of lung function in COPD 
patients.2 In addition, patients with COPD exhibit a chronic inflammatory response 
of the airways, with a persistent inflammation within the proximal airways mainly 
characterized by an endoluminal influx of neutrophils and overproduction of mucus 
and proinflammatory cytokines.3 The airways of these patients are often colonized Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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by mucoid bacteria attached to epithelium by a biofilm and 
purulent sputum is strongly associated with bacterial growth 
in COPD exacerbations.4
Leptin, initially discovered as a regulator of food intake 
and energy expenditure, is emerging as a pleiotropic cytokine 
involved in the recruitment, activation and survival of inflam-
matory cells.5 In particular, via short and long isoforms of its 
receptor, it is able to regulate a variety of cell types including 
neutrophils, eosinophils, T-lymphocytes, and monocytes,6–8 
and to activate neutrophils by the release of reactive oxygen 
species (ROS).9,10 Studies performed in age- and gender-
matched patients with stable COPD have demonstrated that 
plasma soluble form of intercellular adhesion molecule-1 
(sICAM-1) can be considered a marker of inflammation11 and 
that its levels are positively correlated with body mass index 
(BMI) and tumor necrosis factor alpha(TNF-α).12 Moreover, 
temporary disturbances in the energy balance are present 
during an acute exacerbation of COPD and are related to 
increased leptin concentrations and to the systemic inflam-
matory response.13 Accordingly, leptin and TNF-α serum 
levels are significantly higher in the patients experiencing 
exacerbation than in stable COPD patients and controls.14 
However, a number of studies have addressed the presence of 
leptin and its receptor in the lung.15,16 Leptin deficiency might 
be associated with increased susceptibility to infections17,18 
and an assessed role of leptin in bacterial pneumonia in 
mice19 suggests a protective effect of this adipokine against 
infections. Leptin is detectable in induced sputum of COPD 
patients, and it is positively correlated with the inflammatory 
markers C-reactive protein and TNF-α in sputum, indicating 
that leptin is involved in the local inflammatory responses in 
COPD.20 Furthermore, increased levels of leptin expression 
were observed in the submucosa of bronchial biopsies from 
COPD and it is inversely correlated with the apoptosis of 
inflammatory cells,15 suggesting that leptin might regulate 
the inflammatory cell infiltration of the submucosa in COPD. 
Moreover, the effect of smoking cessation in the leptin/lep-
tin receptor pathway is largely unexplored. Based on this, 
the aim of the present work is to explore whether plasma 
and induced sputum concentrations of leptin are related to 
inflammatory markers, such as TNF-α and sICAM-1 and 
neutrophilic airway inflammation in stable COPD patients 
current and former smokers.
Materials and methods
Patients
Twenty-seven stable COPD patients, matched for age and 
BMI as a marker of nutritional status, were enrolled. BMI 
was expressed as kg/m2. To eliminate the effects of gender 
differences, all patients were male. Diagnosis of COPD was 
based on the combination of clinical history and functional 
data.1
All patients were in a stable condition, as defined by the 
absence, for at least 4 weeks, of clinical signs or symptoms 
of acute exacerbation. All subjects were under treatment 
with long-acting beta-adrenergic agonist (salmeterol 50 µg 
twice daily).
Exclusion criteria were history of COPD with severe co-
morbidities (tumors, end-stage New York Heart Association 
III/IV heart failure classes, severe renal failure, liver diseases, 
dementia). All patients had a history of cigarette smoking, 20 
having quit smoking for at least 2 years and 7 still smoking. 
Informed consent was obtained from the patients before 
enrolment into the study.
Functional pulmonary evaluation
FEV1, FEV1/FVC, maximal inspiration pressure (MIP), 
maximal expiration pressure (MEP) and residual volume/
total lung capacity (RV/TLC) were measured with standard 
body plethysmography (1805 Series Plethysmograph, 
MedGraphics). Data are expressed as percentage of predicted 
values. Arterial blood gas analysis was performed using 
standard methods (IL 1400 BG Electrolytes Analyser, 
Instrumentation Laboratory, Milan).
Blood samples
Blood was collected in an EDTA tubes vacutainer (Becton-
Dickinson) in fasting patients in the morning before sputum 
induction. Blood samples were centrifuged at 1000 g for 
15 minutes and plasma was stored at −70°C until analysis.
cytokines assays
Leptin, sICAM-1, and TNF-α were measured in plasma 
and induced sputum supernatant by commercially available 
specific enzyme immunoassay kits ELISA (R&D Systems, 
Minneapolis, MN) according to the manufacturer instruc-
tions. Lower detection limits were 7.8 pg/mL, 0.35 ng/mL, 
and 0.12 pg/mL respectively. Plasma leptin and sICAM-1 
are expressed as ng/mL and TNF-α as pg/mL. In induced 
sputum, leptin and TNF-α are expressed as pg/g of sputum 
and sICAM-1 as ng/g of sputum.
sputum induction and processing
Sputum was induced by inhalation of 3% sterile hypertonic 
saline by a De Vilbiss Ultraneb 99 ultrasonic nebulizer 
(Healthcare Inc, Somerset, PA) through a mouthpiece   without Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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using valves or nose clips, as previously described.21,22 
  Sputum was processed according to the methods of the 
plugs.23 Briefly, the selected plugs were diluted with 4 vol-
umes of phosphate-buffered saline (PBS 1X; Gibco). The 
resulting suspension was vortexed for 30 seconds and then 
centrifuged at 1000 g for 20 minutes. The supernatant was 
collected and stored at –70°C until analysis. The pellet was 
resuspended in 4 volumes of fresh 0.1% dithiothreitol (DTT) 
(Sigma-Aldrich, St Louis, MO) in PBS and processed as 
previously described.24
Cytospins were prepared on aptex (3-aminopropiltryetox-
isilane) -coated slides by adding 100 µL of cell suspension 
(about 5 × 105 cells/mL) into a Shandon II cytocentrifuge at 
180 g for 5 minutes. Differential cell counts were performed 
by May-Gruenwald-Giemsa staining. In all cases 400 non-
squamous cells were counted by 2 blind observers and results 
were expressed as percentage of total nonsquamous cells. 
Air-dried slides for immunocytochemistry were fixed in peri-
odate-lysine-paraformal for 30 minutes and in 15% sucrose 
in Dulbecco’s phosphate-buffered saline for 30 minutes25,26 
and stored at −70°C until immunocytochemical staining.
Immunocytochemical staining
Slides were incubated with a rabbit polyclonal antibody Ob 
anti-leptin (A-20, 1:20 dilution in antibody diluent, 1 hour at 
room temperature), and with a goat-polyclonal antibody Ob-R 
antileptin receptor against the common part of the short and long 
isoforms (M-18, 1:15 dilution in antibody diluent, overnight, 
4°C).27 Both antibodies were from Santa Cruz Biotechnology, 
CA. The reaction was revealed by LSAB KIT phosphatase 
method according to the manufacturer’s instructions. Both 
antibody diluent reagent and LSAB KIT were from DAKO 
Glostrup Denmark. Control slides for leptin were prepared as 
described: the immunocomplex was obtained by immunopre-
cipitation (A/G plus-agarose; Santa Cruz Biotechnology), and 
by incubation with the rabbit-polyclonal antibody Ob (2 µg/mL) 
and human recombinant leptin (20 µg/mL) (Sigma-Aldrich) 
overnight at 4°C. Control slides for leptin receptor were prepared 
by using an irrelevant mouse antibody of the same isotype and 
at the same concentration of the specific primary mAb (Dako). 
The cell nuclei were stained for 1 minute with hematoxylin 
(Dako). Slides were evaluated using a Leica (Wetzlar, Germany) 
microscope at 400 × magnification. Cell identification was 
based on cell morphology under light microscopy (400 × final 
magnification), carefully referring to the cell type distribution in 
corresponding Diff-Quik-stained slides; red staining identified 
positive cells. Two independent observers counted a minimum 
of 600 cells, and the mean value of the 2 observations was used 
(r = 0.91). The results were expressed as positively staining cells 
as a percentage of the total cell number.
statistical analysis
Medians and 25% to 75% percentiles of measured parameters 
were calculated to perform descriptive analysis of population. 
A nonparametric Mann–Whitney test was applied to test the 
differences between the two groups of subjects. Correlations 
were determined using a Spearman rank correlation. Values 
of P , 0.05 were considered statistically significant.
Results
Demographic characteristics 
of the patients
Demographic characteristics of the patients are reported in 
Table 1. Smoker and former smoker COPD patients were 
classified as stable GOLD II. No statistical differences were 
detected between smokers and former smokers for pulmonary 
functional parameters and BMI and body weight.
cytokines concentrations 
and correlations in plasma and sputum
A positive correlation was found between plasma leptin 
levels and BMI (Rho = 0.63; P = 0.001) (Figure 1A) and 
between plasma leptin levels and patient weight (Rho = 0.69; 
P = 0.0006) (Figure 1B), whereas plasma leptin levels were 
inversely correlated with plasma TNF-α levels (Rho = −0.44, 
P = 0.02) (Figure 1C). Plasma TNF-α levels were positively 
correlated with plasma sICAM-1 levels (Rho = 0.47, P = 0.02) 
(Figure 1D). No correlation was found between plasma leptin 
Table 1 Demographic, functional and nutritional characteristics 
of the cOPD patients
Smokers, n = 7 Ex-smokers, n = 20 P
Age  61 (60.2–70) 73 (68–77) ns
FeV1 (%) 44 (30–77.7) 58.5 (41.5–69.5) ns
FeV1/FcV  45 (41.5–60) 58 (49–68.5) ns
pO2 (mmhg) 66 (57.5–78.5) 77.5 (70–80) ns
pcO2 (mmhg) 38.8 (37–43.7) 40 (38–44) ns
MIP 62 (41–93) 64 (49–85) ns
MeP 58.5 (28.5–71) 54 (42.7–66.2) ns
RV/Tlc 58 (47.7–64.7) 55 (50–58) ns
Weight (kg) 70 (63.2–74.7) 69 (60.5–81) ns
BMI (kg/m2) 24.9 (22.9–27.1) 25.3 (23.5–29.6) ns
Pack-year 46 (39.2–90.7) 49 (24–84.5) ns
Notes: Results are expressed as median and 25%–75% percentiles; statistical significance 
between the two groups was detected by a nonparametric Mann–Whitney test.
Abbreviations: BMI, body mass index; FeV1, forced expiratory volume in 1 second; 
FVc,  forced  vitality  capacity;  MIP,  maximal  inspiration  pressure;  MeP,  maximal 
expiration pressure; pcO2, partial pressure of carbon dioxide; pO2, partial pressure 
of oxygen; RV/Tlc, residual volume/total lung capacity.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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and sICAM-1 levels (data not shown). A significant positive 
correlation was present between sputum leptin levels and 
FEV1/FVC (Rho = 0.39, P = 0.04) (Figure 2A) in all COPD 
patients. Significantly increased concentrations of leptin were 
present in sputum of former smokers compared with current 
smokers (Table 2). Additionally, we observed a nonsignificant 
trend toward increased concentrations of TNF-α in sputum 
of former smokers in comparison with current smokers 
(Table 2). Furthermore, no statistically significant differences 
were found between the two groups of COPD patients for 
leptin, TNF-α, and sICAM-1 in plasma (Table 2).
Total and differential cell counts 
in sputum
Total and differential cell counts of induced sputum cells 
were performed in all COPD patients, both smokers and 
former smokers. No statistical significant differences were 
found between smokers and former smokers in either of these 
cell counts (Table 3).
Leptin and leptin receptor expression  
by induced sputum cells
The expression of leptin and its receptor was evaluated in 
  sputum cells from both smoker and former smoker COPD 
patients. The expression of leptin receptor was significantly 
increased in neutrophils of former smokers compared with 
current smokers (Figure 2A; Figure 3), but no difference was 
observed for leptin. No differences were detected for both leptin 
and leptin receptor expression between the two COPD groups 
in macrophages, lymphocytes, and eosinophils (Table 3). 
Additionally in former smokers, leptin and leptin receptor were 
positively correlated (Rho = 0.74, P = 0.02) (Figure 4).
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Figure 1 In cOPD patients plasma leptin levels were positively correlated with body mass index (A) and patient weight (B); plasma TnF-α levels were inversely correlated 
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Discussion
COPD is a pulmonary disease recognized to have important 
systemic and airway inflammatory effects.28 The present 
study underlines that leptin is involved in local and systemic 
inflammation of smoker and former smoker COPD patients, 
matched for age, gender, pulmonary function, and BMI and 
body weight. Additionally, taking into account the crucial 
role of neutrophils in this inflammatory disease, the study 
suggests that the leptin/leptin receptor pathway may con-
tribute to increase the host defense by neutrophils in COPD 
patients after smoking cessation, driving the neutrophil func-
tion. Therefore, because of this study’s small sample size we 
recommend an explorative study.
Leptin is proinflammatory adipokine involved in different 
inflammatory diseases such as rheumatoid arthritis.29 It is 
  produced mainly by fat tissue and is always correlated with 
BMI and TNF-α and is also higher in obese individuals. 
Accordingly, this study and previous studies show that stable 
COPD patients have a positive correlation between plasma lep-
tin levels and patient BMI30,31 as well as with plasma sICAM-1 
and plasma TNF-α.12 In addition, we show that plasma leptin 
levels are positively correlated with body weight, but inversely 
correlated with plasma TNF-α levels. We did not identify a 
positive   correlation between plasma leptin and TNF-α levels, 
or between leptin and sICAM-1   levels in stable COPD, in 
accord with previous studies showing that serum leptin and 
serum TNF-α levels are   significantly higher in patients expe-
riencing exacerbation than in stable patients and controls.20 
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Figure 2 In cOPD patients sputum leptin levels were positively correlated with forced expiratory volume in 1 second/forced vitality capacity (FeV1/FVc) ratio. correlation 
was determined using a spearman rank correlation. P , 0.05 was statistically significant. (A) The expression of leptin receptor was significantly higher in sputum neutrophils 
from former smokers than current smoker patients. The percentage of positive cells was normalized for the total cell counts. a nonparametric Mann–Whitney test was 
applied and differences were considered significant at P , 0.05 (B).
Table 2 evaluation of cytokines in sputum and plasma
Plasma Smokers, n = 7 Ex-smokers, n = 20 P
leptin (ng/ml) 7.7 (3.8–9.2) 10.2 (6.7–13.6) ns
TnF-α (pg/ml) 1.9 (1.1–2.2) 2 (1.3–2.5) ns
sIcaM–1 (ng/ml) 394 (280.5–466.2) 400 (309.9–466.6) ns
Sputum
leptin (pg/g) 7.8 (7.8–9) 50.2 (0–95.7) 0.04
TnF-α (pg/g) 20.7 (5.8–36) 26.4 (9.3–86.9) ns
sIcaM-1 (ng/g) 45.1 (37–8.7) 64.3 (21.4–117.4) ns
Notes:  Results  are  expressed  as  median  and  25%–75%  percentiles;  statistical 
significance  between  the  two  groups  was  detected  by  a  nonparametric  Mann–
Whitney test.
Abbreviations: sIcaM-1, soluble form of intercellular adhesion molecule-1; TnF, 
tumor necrosis factor.
Table  3  Total  and  differential  cell  counts  in  sputum  and 
immunocytochemistry
Smokers Ex-smokers P
n = 7 n = 20
Total cell counts 
(mL/g sputum)
3.1 (1.85–14.14) 9.7 (5.08–22.37) ns
Differential cell 
counts (%)
neutrophils 82 (55.1–84.1) 78 (59.8–90.3) ns
Macrophages 12.4 (6.7–33.8) 9.8 (5–34) ns
Lymphocytes 2.1 (2–5.1) 1.4 (0.9–2.3) ns
eosinophils 3.3 (0.5–4.2) 0.8 (0–3.3) ns
Leptin expression 
(% positive cells)
n = 6 n = 10
neutrophils 13.2 (0–33.3) 16.2 (12.5–62.8) ns
Macrophages 62.7 (28.6–69.6) 47.2 (8.1–80.4) ns
Lymphocytes 0 (0–0) 0 (0–0) ns
eosinophils 30.9 (0–90) 37.5 (0–100) ns
Leptin receptor 
expression 
(% positive cells)
neutrophils 1 (0–10) 4.3 (0–75) 0.02
Macrophages 11.5 (0–28.6) 17.1 (0–75) ns
Lymphocytes 0 (0–0) 0 (0–10) ns
eosinophils 29 (0–80) 33.3 (0–100) ns
Notes: Results are expressed as median and 25%–75% percentiles; statistical significance 
between the two groups was detected by a nonparametric Mann–Whitney test.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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Additionally, a previous study showed that leptin levels are 
lower and TNF-α levels are higher in stable patients than in 
patients experiencing exacerbation,14 strongly supporting the 
negative correlation between plasma leptin and TNF-α levels 
identified in our patients. Furthermore, sICAM-1 and leptin 
concentrations are significantly higher in patients with higher 
levels of BMI31–33 than in COPD patients enrolled in our   
study.
Clinical and functional FEV1/FVC ratio is considered 
the most important altered parameter of lung function in 
COPD patients. A previous study has already shown that 
respiratory pathogens isolated from the sputum are associ-
ated with severe airflow obstruction (FEV1/FVC , 60%).34 
We demonstrate here that sputum leptin levels were 
positively correlated with the FEV1/FVC values in COPD 
patients studied, hence it is possible to consider a possible 
relationship between leptin and the resolution of airway 
infection in COPD patients. However, since we selected 
patients in a stable condition, we observed only little cor-
relation. COPD patients exhibit a chronic inflammatory 
response of the airways with a persistent inflammation 
characterized by an increased influx of neutrophils at the 
site of inflammation.3 The role of neutrophils in COPD 
is very important because they play a pivotal role in the 
defense against infections and are critically involved in 
the innate defense mechanisms.34 The infections are criti-
cal events that complicate COPD and lead to the progres-
sive decrease of lung function.35 Also, smoking attenuates 
the oxidative burst of inflammatory cells and 3 weeks of 
abstinence normalizes the oxidative burst.36 These results 
suggest that smoking cessation improves the function and 
activity of inflammatory cells. We have demonstrated that 
sputum leptin and TNF-α levels are higher in sputum of 
former smoker than in current smoker COPD patients. We 
found these differences only in the airway leptin system of 
stable COPD patients due to a direct action of the cigarette 
smoke in the airways. To our knowledge, only one study has 
assessed the relationship between leptin and other cytokines 
in sputum of COPD patients, suggesting a specific role of 
this adipokine in the local inflammatory response in COPD20 
Smokers (n = 6) Ex-smokers (n = 10)
L
e
p
t
i
n
 
e
x
p
r
e
s
s
i
o
n
C B A
F E D
10 µm
10 µm 10 µm
10 µm 10 µm
10 µm
L
e
p
t
i
n
 
r
e
c
e
p
t
o
r
 
e
x
p
r
e
s
s
i
o
n Negative control
Figure 3 Immunocytochemistry for leptin and its receptor expression in sputum cells: leptin receptor expression was significantly lower in sputum neutrophils from current 
smokers (A) than former smokers (B). negative control for leptin receptor (C). leptin expression was lower in sputum neutrophils from current smoker patients (D) 
than in former smoker patients (E). negative control for leptin (F). arrows indicate sputum neutrophils. lines indicate sputum macrophages, double arrow squamous cells, 
circular arrow indicate bronchial epithelial cells.
Rho = 0.74
P = 0.02
%
 
l
e
p
t
i
n
 
+
 
n
e
u
t
r
o
p
h
i
l
s
 
% leptin receptor + neutrophils 
Ex-smokers( n = 9)
−10
10
30
50
70
90
110
−101 03 0 50 70 90 110
Figure 4 Leptin expression was positively correlated with its receptor in sputum 
neutrophils from former smoker cOPD patients. The percentage of positive cells 
was  normalized  for  the  total  count  cells.  correlation  was  determined  using  a 
spearman rank correlation. P , 0.05 was statistically significant.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
57
leptin and inflammation in cOPD
but not clarifying the specific role of cigarette smoke in 
these mechanisms. Our results strengthen the hypothesis 
that quitting smoking might increase the leptin action in host 
defense mechanism from respiratory pathogens mediated by 
sputum neutrophils. Indeed, we show here for the first time 
the expression of leptin together with its receptor in sputum 
neutrophils in COPD patients and that the expression of 
leptin and its receptor is higher in former smoker than in 
current smoker COPD subjects and that these parameters 
are positively correlated only in former smokers. In addition 
the increased levels of leptin in the induced sputum from 
former smokers together with higher levels of TNF-α might 
be associated with the capacity of TNF-α to increase the lev-
els of leptin expression37,38 or to the increased appetite after   
smoking cessation.39 Neutrophils express the short form of 
leptin receptors7 and despite lacking the STAT3 docking 
site, the short leptin receptor isoform is still able to bind 
and activate Jak2, which subsequently activates the MAPK 
pathway in leptin-stimulated neutrophils.40 The MAPK 
pathway is important for cytoskeletal processes, such as 
those involved in the transfer of CD11b from cytoplasmic 
granules to the plasma membrane, and for the generation 
of reactive oxygen species.41,42 Leptin is able to stimulate 
neutrophils by increasing CD11b expression indirectly 
via monocyte-derived TNF-α9 and since a leptin-induced 
ICAM-1 expression was observed in eosinophils43 one of 
the mechanisms by which leptin affects neutrophil activity 
might be associated with the induction of the expression 
of ICAM on neutrophils of COPD patients.
Additionally, it has been reported that reactive oxygen 
production is the consequence of a direct stimulation of neu-
trophils by leptin10 and that exogenous leptin administration 
in vivo or in vitro could induce the phagocytic activity in 
leptin-deficient purified mouse neutrophils.17 Together, this 
evidence suggests that leptin and its receptor are strongly 
involved in the activation of neutrophils, as supported by our 
results showing a positive correlation between leptin and its 
receptor in sputum neutrophils of former smokers. Indeed 
our patients, well matched for BMI and body weight, did not 
show differences in neutrophils in sputum cells from COPD 
and COPD former smokers, in contrast with previous results44 
obtained in a study population of COPD not matched for 
nutritional status. TNF-α is a proinflammatory cytokine with 
pleiotropic effects produced in the lung mainly by activated 
macrophages in response to inflammatory stimuli such as 
a chemoattractant for inflammatory cells.45,46 TNF-α levels 
are higher in patients experiencing COPD exacerbation14 and 
TNF-α receptors are significantly elevated in sputum from 
ex-smoker compared with current smoker COPD patients.47 
We did not identify significant differences between TNF-α 
levels in sputum and plasma from COPD former smokers 
and smokers, although some of our patients reached higher 
levels of TNF-α due to the fact that our patients were in a 
stable condition.
Although our study has some limitations because of 
the small number of patients, it is the first study to analyze   
the expression of the leptin/leptin receptor pathway in sputum 
cells from COPD patients in relation to the smoking habit of 
the patients. However our results, in accord with those of a 
previous study,20,48 underline the fact that the levels of leptin 
together with TNF-α, in the inflammatory context of COPD, 
are more involved in the local inflammatory response of the 
lung than in the systemic circulation. Finally, our findings 
underline the correlation between leptin sputum levels and 
FEV1/FVC ratio in COPD patients together with the increased 
leptin levels in patients who have quit smoking, supporting 
the concept of a protective role of leptin in COPD with a 
deleterious effect of cigarette smoke. Our observation is 
further supported by the fact that the expression of leptin 
is correlated positively with the expression of its receptor 
in sputum neutrophils from former smoker COPD patients, 
leading us to suppose that cigarette smoke might affect the 
leptin/leptin receptor-mediated neutrophil activation. All 
these data could explain a long-term follow-up improvement 
of the pulmonary function in COPD patients after smoking 
cessation mediated by leptin neutrophils activation.
Taken together these findings strongly suggest that leptin 
plays a role in the activation of neutrophils in the airways of 
COPD patients and that leptin is involved in the protection of 
the airways of these patients. This effect is likely exerted via 
the role played by neutrophils in innate immune mechanisms 
against infections and is counteracted by the persistence of 
cigarette smoke exposure. To better identify the role of leptin 
in sputum neutrophils from COPD former smokers further 
studies are needed to analyze COPD patients before and after 
smoking cessation.
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